Development and validation of Japanese version of Alzheimer's disease Cooperative Study scale for ADL in MCI (ADCS-MCI-ADL)

Development and validation of Japanese version of Alzheimer's disease Cooperative Study scale for ADL in MCI (ADCS-MCI-ADL) - Development and validation of Japanese version of ADCS-MCI-ADL

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000055015

Enrollment

120

Registered

2024-07-18

Start date

2024-03-11

Completion date

Unknown

Last updated

2026-09-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Alzheimer&#39

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: <Inclusion criteria> - Diagnosis of MCI due to AD or ADD according to the National Institute on Aging-Alzheimer's Association 2011 criteria - Clinical Dementia Rating (CDR) global score < 2 - Over 40 years old - Existence of caregivers who are familiar with participant's daily livings - Written informed consent was obtained from patients and/or caregivers. <Inclusion criteria for healthy control> - Over 40 years old - Absence of subjective cognitive decline - Absence of obvious cognitive impairment - Absence of obvious disability in ADL - Written informed consent was obtained from participants

Exclusion criteria

Exclusion criteria: <Exclusion criteria> - Drug induced, or vascular dementia - Existence of severe medical disease - Comorbidity of other psychiatric disease such as schizophrenia, mood disorders, or drug abuse - Judgment made by the research director/co-researcher that study participation would negatively influence the patient's condition <Exclusion criteria for healthy control> - Existence of psychiatric or neurological disease that impair the cognitive function

Design outcomes

Primary

Measure	Time frame
Reliability, validity, and interpretability of ADCS-MCI-ADL-J	—

Countries

Japan

Contacts

Public ContactDaiki Ishimaru

Osaka University Hospital Department of Medical Technology

d.ishimaru@psy.med.osaka-u.ac.jp06-6879-3051

Outcome results